Lifeward (LFWD) Receivables - Other (2014 - 2015)
Lifeward (LFWD) reported Receivables - Other of $242000.0 for Q4 2015, up 12.56% on a YoY basis from $215000.0 in Q4 2014, and up 12.56% sequentially from $215000.0 in Q4 2014.
Lifeward (LFWD) Receivables - Other (2014 - 2015) Analysis & Trends
Lifeward (LFWD) has 2 years of Receivables - Other data on file, last reported at $242000.0 in Q4 2015.
- For the quarter ending Q4 2015, Receivables - Other rose 12.56% year-over-year to $242000.0; the trailing twelve-month figure through Dec 2015 stood at $242000.0 (up 12.56% YoY), and the FY2015 full-year result was $242000.0, up 12.56% from the prior year.
- Receivables - Other climbed to $242000.0 in Q4 2015, from $215000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $242000.0 in Q4 2015 to a low of $215000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Lifeward | 8.16 Mn | -3.26 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 242,000.00 |
| Dec 31, 2015 | 242,000.00 |
| Dec 31, 2014 | 215,000.00 |
| Dec 31, 2014 | 215,000.00 |